Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUCAS: Bevacizumab vs Ranibizumab in Neovascular AMD
NCT01127360Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Mar 2009
- Primary completion
- Aug 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab in neovascular age-related macular degeneration (NVAMD), sponsored by Oslo University Hospital. Started Mar 2009; status: completed.
02
Drugs
bevacizumab
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT01127360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01127360.